- idUS
- Browsing by Author
Browsing by Author "Nogales-Fernández, Esteban"
Now showing items 1-3 of 3
-
Article
Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
Palazón Carrión, Natalia; Jiménez Cortegana, Carlos; Sánchez-León, M. Luisa; Henao Carrasco, Fernando Manuel; Nogales-Fernández, Esteban; Chiesa, Massimo; Caballero, Rosalía; Rojo, Federico; Nieto García, María Adoración; Sánchez Margalet, Víctor; Cruz Merino, Luis de la (Nature publishing group, 2021)Identifcation of the diferent elements intervening at the tumor microenvironment seems key to explain clinical evolution ...
-
Article
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trial
Jiménez Cortegana, Carlos; Palazón Carrión, Natalia; Martín García-Sancho, Alejandro; Nogales-Fernández, Esteban; Carnicero-González, Fernando; Ríos Herranz, Eduardo; Sánchez Margalet, Víctor; Cruz Merino, Luis de la (BMJ, 2021)Background The search for immunological markers with ability of predicting clinical outcome is a priority in lymphomas, ...
-
Article
Lenalidomide plus R-GDP (R2-GDP) in Relapsed/ Refractory Diffuse Large B-Cell Lymphoma: Final Results of the R2-GDP-GOTEL Trial and Immune Biomarker Subanalysis
Palazón Carrión, Natalia; Martín García-Sancho, Alejandro; Nogales-Fernández, Esteban; Jiménez Cortegana, Carlos; Carnicero-González, Fernando; Ríos Herranz, Eduardo; Sánchez Margalet, Víctor; Rueda Domínguez, Antonio; Cruz Merino, Luis de la (AMER ASSOC CANCER RESEARCH, 2022)Purpose: New therapeutic options are needed in relapsed/refrac tory diffuse large B-cell lymphoma (R/R DLBCL). Lenalidomide ...